These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2306879)

  • 21. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T; Dodds AW; Law SK; Inoue K
    Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of homozygous C4B deficiency with bacterial meningitis.
    Rowe PC; McLean RH; Wood RA; Leggiadro RJ; Winkelstein JA
    J Infect Dis; 1989 Sep; 160(3):448-51. PubMed ID: 2788199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
    Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo.
    Venneker GT; Westerhof W; de Vries IJ; Drayer NM; Wolthers BG; de Waal LP; Bos JD; Asghar SS
    J Invest Dermatol; 1992 Dec; 99(6):853-8. PubMed ID: 1469300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited human complement C5 deficiency. Nonsense mutations in exons 1 (Gln1 to Stop) and 36 (Arg1458 to Stop) and compound heterozygosity in three African-American families.
    Wang X; Fleischer DT; Whitehead WT; Haviland DL; Rosenfeld SI; Leddy JP; Snyderman R; Wetsel RA
    J Immunol; 1995 May; 154(10):5464-71. PubMed ID: 7730648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first.
    Hughes AL
    Mol Biol Evol; 1994 May; 11(3):417-25. PubMed ID: 8015436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Mutations Causing C5 Deficiency in Three North-African Families.
    Colobran R; Franco-Jarava C; Martín-Nalda A; Baena N; Gabau E; Padilla N; de la Cruz X; Pujol-Borrell R; Comas D; Soler-Palacín P; Hernández-González M
    J Clin Immunol; 2016 May; 36(4):388-96. PubMed ID: 27026170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
    Ebanks RO; Isenman DE
    J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
    Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype.
    Fasano MB; Winkelstein JA; LaRosa T; Bias WB; McLean RH
    J Clin Invest; 1992 Oct; 90(4):1180-4. PubMed ID: 1401055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activation mechanism of human complement system by immune precipitate formed with rabbit IgG antibody.
    Fujita T
    Microbiol Immunol; 1979; 23(10):1023-31. PubMed ID: 514094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.
    Franco-Jarava C; Comas D; Orren A; Hernández-González M; Colobran R
    Clin Exp Immunol; 2017 Aug; 189(2):226-231. PubMed ID: 28369827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of null C4 alleles on complement function.
    Welch TR; Beischel L; Berry A; Forristal J; West CD
    Clin Immunol Immunopathol; 1985 Mar; 34(3):316-25. PubMed ID: 3844325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement component C5 and C6 mutation screening indicated in meningococcal disease in South Africa.
    Owen EP; Leisegang F; Whitelaw A; Simpson J; Baker S; Würzner R; Potter P; Orren A
    S Afr Med J; 2012 May; 102(6):525-7. PubMed ID: 22668955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.